Cytek Biosciences Inc. (CTKB)
NASDAQ: CTKB
· Real-Time Price · USD
3.31
0.09 (2.80%)
At close: Jun 16, 2025, 3:59 PM
3.30
-0.15%
After-hours: Jun 16, 2025, 04:32 PM EDT
2.80% (1D)
| Bid | 3.08 |
| Market Cap | 418.61M |
| Revenue (ttm) | 197.05M |
| Net Income (ttm) | -11.25M |
| EPS (ttm) | -0.09 |
| PE Ratio (ttm) | -36.72 |
| Forward PE | -48.07 |
| Analyst | Hold |
| Ask | 3.8 |
| Volume | 1,266,603 |
| Avg. Volume (20D) | 1,078,625 |
| Open | 3.25 |
| Previous Close | 3.22 |
| Day's Range | 3.18 - 3.35 |
| 52-Week Range | 2.37 - 7.63 |
| Beta | 1.26 |
About CTKB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTKB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTKB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-22.69%
Cytek Biosciences shares are trading lower after t...
Unlock content with
Pro Subscription
3 months ago
-6.65%
Cytek Biosciences shares are trading lower after the company reported worse-than-expected Q4 revenue results and issued FY25 revenue guidance below estimates.
